Scarica l'app Stockscreener
10.08
0.30%
0.03
Drugs Made In America Acquisition Ii Corp Borsa (DMII) Ultime notizie
DMII Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Price to book forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
Price to sales forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
Price to book forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMIIR - TradingView
Price to sales forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMIIR - TradingView
Feis Equities and Lawrence Feis disclose 5.08% ownership in DMAA (DMAA) - Stock Titan
Price to sales forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAU - TradingView
Enterprise value to revenue forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAU - TradingView
Enterprise value to EBITDA forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAU - TradingView
Price to earnings forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Enterprise value to EBITDA forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Price to sales forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Enterprise value to revenue forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 - TradingKey
Drugs Made In America Acquisition Corp - TradingKey
Number of shareholders of Drugs Made In America Acquisition II Corp. – NASDAQ:DMIIU - TradingView
Drugs Made In America Acquisition Corp (DMAAU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Institutional Confidence - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Institutional Confidence - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Drugs Made In America Acquisition II Units - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
DMAAR Rights Trade Flat Near All-Time Low as Investors Await Merger CatalystBearish Pattern Stocks - newsline.com
DMAA Hovers Near $10.62 as SPAC Consolidates Ahead of Potential CatalystFair Value Gap - newsline.com
US Retreat from Global Leadership Stirs Uncertainty Across AsiaFinancial Health Score - newsline.com
DMAAR Rights Hold Steady at $0.10: Analyzing the Stalemate for Drugs Made In America Acquisition Corp.Channel Breakout - newsline.com
Drugs Made In America Acquisition II Corp. Right (DMIIR) Holds Flat at $0.08 as Rights Trading Remains DormantDip Buy Trade - newsline.com
Omega Healthcare Investors (OHI) Rises 1.08% as Real Estate Sector Finds FootingBull Pennant - newsline.com
DMII Holds Steady at $10.08: SPAC Trading in a Narrow RangeTICK Divergence - newsline.com
DMIIU Holds Steady at $10.12 as SPAC Unit Trades in Tight RangeFear Greed Extreme - newsline.com
DMIIR Rights Trading Slumps 9.09% to $0.08 – Micro-Cap Struggles for DirectionReversal Setup Alerts - newsline.com
0.16%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):